Zydus receives approval from COFEPRIS to market? Mamitra to treat various cancers
The drug will be marketed in different strengths of 150 mg and 440 mg and used in the treatment of patients with HER2
The drug will be marketed in different strengths of 150 mg and 440 mg and used in the treatment of patients with HER2
Rusan’s API facility in Ankleshwar is GMP approved by other stringent international agencies as well
The acquisition is immediately accretive and creates a compelling, single-stop, multi-continent partner for biopharma companies
Ashland's nutraceuticals business supplies a broad portfolio of active ingredients and formulation aids to nutritional product companies
Approval from Colombia's INVIMA will accelerate growth in Colombia, by registering our product and getting regular supplies
The facility will manufacture tablets, capsules, and injections for the oncology segment
The MDC business produces components for medical device manufacturers globally with a focus on precious metal alloys and nitinol
Winlevi is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older
Zydus’s revenue growth was led by India and EU formulations businesses in addition to that in the emerging markets.
The agreement grants Brinter the distribution rights of GrowInk bioinks in many countries
Subscribe To Our Newsletter & Stay Updated